Colony Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$266K Sell
19,110
-19
-0.1% -$243 ﹤0.01% 670
2023
Q2
$225K Buy
19,129
+284
+2% +$3.23K ﹤0.01% 724
2023
Q1
$217K Buy
+18,845
New +$233K ﹤0.01% 734
2020
Q1
Sell
-12,532
Closed -$267K 761
2019
Q4
$267K Buy
+12,532
New +$281K 0.01% 661

Other funds holding SBRA

Colony Group's SBRA Position: Q3 2023 in Review

Colony Group reduced its Sabra Healthcare REIT (SBRA) stake by 0.1% in Q3 2023, selling an estimated $243 and leaving 19,110 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Colony Group first reported a position in SBRA in Q4 2019 and has held it in 4 quarters since. The position peaked at $267K in Q4 2019. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.

  • Colony Group held 19,110 shares of Sabra Healthcare REIT worth $266K as of Q3 2023.
  • Colony Group sold 19 Sabra Healthcare REIT shares in Q3 2023, an estimated $243.
  • Sabra Healthcare REIT made up ﹤0.01% of Colony Group's portfolio in Q3 2023, its #670 holding.
  • Colony Group first reported a position in Sabra Healthcare REIT in Q4 2019 and has held it in 4 quarters since.
  • Colony Group's Sabra Healthcare REIT position peaked at $267K in Q4 2019.
  • 329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.